首页 | 本学科首页   官方微博 | 高级检索  
     


Nilotinib can override dasatinib resistance in chronic myeloid leukemia patients with secondary resistance to imatinib first-line therapy
Authors:Breccia Massimo  Cannella Laura  Nanni Mauro  Stefanizzi Caterina  Alimena Giuliana
Affiliation:Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy. breccia@bce.uniroma1.it
Abstract:
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号